证券代码：301207 证券简称：华兰疫苗 公告编号：2025-037 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 华兰生物疫苗股份有限公司 第二届董事会第十六次会议决议公告 一、董事会会议召开情况 华兰生物疫苗股份有限公司（以下简称"公司"）第二届董事会第十六次会议于 2025年8月18日以电话或电子邮件方式发出通知，于2025年8月27日以通讯表决方式 召开，会议应出席董事9名，实际出席董事9名。会议的召集和召开符合《公司法》 和《公司章程》的有关规定。 二、董事会会议审议情况 1、会议以 9 票同意，0 票反对，0 票弃权的表决结果通过了《2025 年半年度报 告及其摘要》。 公司严格按照《证券法》及《深圳证券交易所创业板股票上市规则》等有关规 定，完成了 2025 年半年度报告的编制工作。公司董事、高级管理人员对该报告签署 了书面确认意见。 该议案已经公司第二届董事会 2025 年第四次审计委员会会议审议通过。公司审 计委员会认为，公司编制的 2025 年半年度报告的程序符合法律、行政法规和中国证 监会的规定，报告内容真实、准确、完整地反映了上市公 ...

华兰生物疫苗股份有限公司 关于2025年中期利润分配预案的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、华兰生物疫苗股份有限公司2025年中期利润分配预案为：以595,000,033股（已 扣除公司回购专用证券账户中的股份6,027,467股）为基数，向全体股东每10股派发 现金红利6元（含税），共计357,000,019.80元；不送红股，不进行资本公积金转增 股本，剩余未分配利润结转以后年度。 若本次利润分配预案披露日至实施该方案的股权登记日期间，如享有利润分配 权的股本总数发生变动，则以实施分配方案时股权登记日的享有利润分配权的股本 总数为基数，按照分配比例不变的原则对分配总额进行调整。 2、公司现金分红方案不涉及《深圳证券交易所创业板股票上市规则》第 9.4 条 相关规定的可能被实施其他风险警示情形。 证券代码：301207 证券简称：华兰疫苗 公告编号：2025-040 一、审议程序 华兰生物疫苗股份有限公司（以下简称"公司"）于 2025 年 8 月 27 日召开了第 二届董事会第十六次会议，审议通过了《关于 2025 年中 ...

华兰生物疫苗股份有限公司 2025 年半年度报告全文 华兰生物疫苗股份有限公司 2025 年半年度报告 二〇二五年八月 1 华兰生物疫苗股份有限公司 2025 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、董事、高级管理人员保证半年度报告内容的真实、准确、 完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法 律责任。 公司负责人安康、主管会计工作负责人路珂及会计机构负责人(会计主管 人员)苏文冬声明：保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本次半年报的董事会会议。 公司已在本报告中详细描述可能存在的相关风险，敬请查阅本报告第三 节管理层讨论与分析中"公司面临的风险和应对措施"章节的相关内容。 公司经本次董事会审议通过的利润分配预案为：以 595,000,033 股为基数， 向全体股东每 10 股派发现金红利 6 元（含税），送红股 0 股（含税），不以公 积金转增股本。 2 | 目录 | | --- | | 第一节 | 重要提示、目录和释义 2 | | --- | --- | | 第二节 | 公司简介和主要财务指标 6 | | 第三节 | 管理层讨论 ...

Core Viewpoint - On August 18, a total of 19 listed companies had their restricted shares unlocked, with a total market value of approximately 32.581 billion yuan [1]. Group 1: Unlocking Details - The specific details of the restricted share unlocks are as follows: - **Sunshine Energy (000591)**: 314 million shares from A-share original shareholder allocation [2] - **Paislin (600215)**: 2.0375 million shares from equity incentive lock-up [2] - **Xin'ao Co. (600803)**: 253 million shares from A-share corporate allocation [2] - **Hualan Biological (301207)**: 459 million shares with extended lock-up period [2] - **Taihe New Materials (002254)**: 436,000 shares from equity incentive lock-up [2] - **Yinxi Technology (300221)**: 569,890 shares from equity incentive lock-up [2] - **Loxin Medical (300562)**: 110,000 shares from equity incentive lock-up [2] - **Bona Film (001330)**: 319 million shares from pre-issue lock-up [2] - **Yuanfei Pet (001222)**: 112 million shares from pre-issue lock-up [2] - **Kaige Precision Machinery (301338)**: 72.1 million shares from pre-issue lock-up [2] - **Dingjide (603255)**: 72.7914 million shares from pre-issue lock-up [2] - **Shangji Technology (301330)**: 18.515 million shares from pre-issue lock-up [2] - **Zhongchumai (688267)**: 83.3928 million shares [2] - **Luwei Optoelectronics (688401)**: 77.6214 million shares [2] - **Haohan Depth (688292)**: 10.8085 million shares [2] - **Huicheng Co. (688403)**: 259 million shares [2] - **Kaiweite (688693)**: 921,100 shares [2] - **Xinyu Ren (688573)**: 122,190 shares [2] - **Sinan Navigation (688592)**: 77,700 shares [2]

Group 1 - The State Council Information Office will hold a press conference on the development of socialist democracy during the "14th Five-Year Plan" period [2] - The 2025 Global Smart Education Conference will take place in Beijing, focusing on the theme of "Human-Machine Collaboration to Foster a New Education Ecosystem" [3] - A total of 26.26 billion shares from 17 companies will be unlocked today, with a total market value of 46.718 billion yuan [4] Group 2 - Four companies have disclosed stock repurchase progress, with two companies announcing new repurchase plans [5][6] - The highest repurchase amounts reported are 20 million yuan and 193,500 yuan for Honghui New Materials and Small Commodity City, respectively [5] - A total of 1,120 billion yuan in 7-day reverse repos will mature today, with an operation rate of 1.40% [7]

格隆汇8月18日｜Wind数据显示，周一（8月18日），共有17家公司限售股解禁，合计解禁量为26.26亿 股，按最新收盘价计算，合计解禁市值为467.18亿元。从解禁量来看，10家公司解禁股数超千万股。格 科微、华兰疫苗、太阳能解禁量居前，解禁股数分别为10.5亿股、4.59亿股、3.14亿股。从解禁市值来 看，10家公司解禁股数超亿元。格科微、华兰疫苗、珂玛科技解禁市值居前，解禁市值分别为163.91亿 元、85.28亿元、48.8亿元。从解禁股数占总股本比例来看，6家公司解禁比例超10%。华兰疫苗、中触 媒、格科微解禁比例居前，解禁比例分别为76.37%、47.33%、40.38%。 ...

Summary of Key Points Core Viewpoint - On August 18, a total of 17 companies had their restricted shares unlocked, with a total unlock volume of 2.626 billion shares, amounting to a market value of 46.718 billion yuan based on the latest closing price [1]. Unlock Volume - 10 companies had an unlock volume exceeding 10 million shares, with GeKomei, Hualan Biological Engineering, and Suntech leading the unlock volume at 1.05 billion shares, 459 million shares, and 314 million shares respectively [1]. Unlock Market Value - 10 companies had an unlock market value exceeding 100 million yuan, with GeKomei, Hualan Biological Engineering, and Kema Technology leading at 16.391 billion yuan, 8.528 billion yuan, and 4.88 billion yuan respectively [1]. Unlock Ratio - 6 companies had an unlock ratio exceeding 10% of their total share capital, with Hualan Biological Engineering, Zhongchumai, and GeKomei having the highest ratios at 76.37%, 47.33%, and 40.38% respectively [1].

Investment Rating - The industry investment rating is maintained at "Overweight" [1] Core Views - The first vaccine product has passed the commercial insurance innovative drug directory review, potentially opening new payment channels for innovative vaccines [3] - The vaccine industry is currently facing performance pressure due to supply-demand imbalances, but long-term prospects remain positive driven by innovation and international expansion [7][29] Summary by Sections Domestic and International Vaccine Dynamics - Hualan Vaccine has received approval for clinical trials of a freeze-dried type B Haemophilus influenzae conjugate vaccine, which is expected to provide protection against infections caused by this pathogen [3] - The "Quadrivalent Influenza Virus Subunit Vaccine" has become the only vaccine to pass the preliminary review for the commercial insurance innovative drug directory, marking a significant step in integrating vaccines into the insurance payment system [3] Market Review - The vaccine sector saw a 1.3% increase last week, with a cumulative increase of 2.28% in 2025 [4][5] - The overall pharmaceutical sector reported a 3.08% increase, with various sub-sectors showing mixed performance [4][10] Valuation - The vaccine sector's PE (ttm) is 81.82X, with a PB (lf) of 1.99X, indicating a slight increase from the previous week [6] Investment Recommendations - The vaccine industry is experiencing performance pressure in 2024 and Q1 2025, but companies are focusing on pipeline adjustments and innovation to improve competitiveness [7][26] - Long-term investment focus should be on companies with strong R&D capabilities and differentiated products, with recommendations for Kangxino and Kanghua Biotech [29]

Core Viewpoint - The upcoming week will see 35 stocks in the A-share market facing the lifting of lock-up restrictions, with a total of 3.942 billion shares being released, amounting to a market value of approximately 99.964 billion yuan, which is a decrease of 56.93% compared to the previous week [1][2]. Summary by Category Stock Unlocking Details - Among the 35 stocks, the largest unlock market value will be from United Imaging Healthcare at over 29 billion yuan, followed by GeKong Microelectronics at over 16 billion yuan, and Hualan Biological Engineering at approximately 8.5 billion yuan [2][4]. - The unlocking dates for key stocks are as follows: United Imaging Healthcare on August 22 with 23.09 million shares, GeKong Microelectronics on August 18 with 105 million shares, and Hualan Biological Engineering on August 18 with 4.59 million shares [2][4]. Market Performance - As of August 15, the stock price changes since August for United Imaging Healthcare, GeKong Microelectronics, and Hualan Biological Engineering are -4.01%, +2.03%, and -2.11% respectively [3]. Unlocking Proportions - Six stocks will see their unlocking shares exceed 50% of their total share capital, including Hualan Biological Engineering (76.37%), GeKong Microelectronics (67.76%), and others, leading to significant increases in their circulating shares [8][9]. - The total number of stocks with a circulation increase of over 100% after unlocking will be eight, including notable increases for Hualan Biological Engineering and GeKong Microelectronics [8]. Detailed Stock Information - The detailed unlocking information for United Imaging Healthcare shows that its largest shareholders include United Imaging Technology Group and Shanghai Ying Sheng Investment Partnership, with a total unlocking of 16.76 million shares valued at approximately 21.44 billion yuan [6]. - For GeKong Microelectronics, the largest shareholder is Uni-sky Holding Limited, with an unlocking of 105 million shares valued at approximately 16.39 billion yuan [7].

Summary of Key Points Core Viewpoint - Next week, 35 stocks in the A-share market will face the unlocking of restricted shares, totaling 3.942 billion shares with a market value of approximately 99.964 billion yuan, a decrease of 56.93% compared to the previous week [1]. Company-Specific Summaries - **Unrestricted Shares and Market Value**: Among the 35 stocks, the largest market value of unlocked shares will be from United Imaging Healthcare at over 29 billion yuan, followed by GeKong Microelectronics at over 16 billion yuan, and Hualan Biological Engineering at approximately 8.5 billion yuan [2][4]. - **Unlock Dates and Share Counts**: United Imaging Healthcare will unlock 23.09 million shares on August 22, GeKong Microelectronics will unlock 1.05 billion shares on August 18, and Hualan Biological Engineering will unlock 4.59 million shares on August 18, all being original shareholders' restricted shares [2][4]. - **Stock Price Performance**: As of August 15, the stock price changes for the month are as follows: United Imaging Healthcare at -4.01%, GeKong Microelectronics at +2.03%, and Hualan Biological Engineering at -2.11% [3]. Unlocking Proportions and Impacts - **High Unlock Ratios**: Six stocks will have over 50% of their total shares unlocked, including Hualan Biological Engineering (76.37%), GeKong Microelectronics (40.38%), and others, leading to significant increases in their circulating shares [8][9]. - **Circulating Share Increases**: After the unlocking, the circulating shares of these six stocks will increase by 324.04%, 210.20%, and 207.77%, respectively, indicating a substantial impact on their liquidity [8][9]. Detailed Unlocking Information - **Top Ten Stocks by Unlock Value**: The top ten stocks by unlock value include United Imaging Healthcare, GeKong Microelectronics, and Hualan Biological Engineering, with respective unlock values of 29.54 billion yuan, 16.39 billion yuan, and 8.53 billion yuan [4][10]. - **Shareholder Details**: The major shareholders unlocking shares for United Imaging Healthcare include United Imaging Healthcare Technology Group and Shanghai Ying Sheng Investment Partnership, with the largest shareholder being United Imaging Healthcare Technology Group [6].